Drug Shortage Report for LOSARTAN
Report ID | 138700 |
Drug Identification Number | 02388804 |
Brand name | LOSARTAN |
Common or Proper name | LOSARTAN |
Company Name | SIVEM PHARMACEUTICALS ULC |
Market Status | DORMANT |
Active Ingredient(s) | LOSARTAN POTASSIUM |
Strength(s) | 50MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2021-05-24 |
Actual start date | 2021-05-26 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2021-05-27 |
Company comments | QA HOLD - Recall 2021-05-26 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2021-05-27 | French | Compare |
v4 | 2021-05-27 | English | Compare |
v3 | 2021-05-25 | English | Compare |
v2 | 2021-05-04 | French | Compare |
v1 | 2021-05-04 | English | Compare |
Showing 1 to 5 of 5